HIV-1 entry and its inhibition

Current Topics in Microbiology and Immunology

Volumn 281, Issue , 2003, Pages 1-27

  Pierson, T C ^a   Doms, R W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALPHA N ACETYLNONA DEXTRO ARGININE AMIDE; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 INHIBITOR; CHEMOKINE RECEPTOR CXCR4; ENFUVIRTIDE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; SCH C; T 1249; T 22; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; BINDING SITE; CELL SURFACE; CONFORMATIONAL TRANSITION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; THERMODYNAMICS; VIRION; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0041663569     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-19012-4_1     Document Type: Review

References (140)

1. Alkhatib, G, Combadiere, C, Broder, CC, Feng, Y, Kennedy, PE, Murphy, PM, and Berger, EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1, Science 272: 1955-1958
2. Allaway, GP, Davis-Bruno, KL, Beaudry, GA, Garcia, EB, Wong, EL, Ryder, AM, Hasel, KW, Gauduin, MC, Koup, RA, McDougal, JS, and et al. (1995) Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates, AIDS Res Hum Retroviruses 11: 533-9
3. Arakaki, R, Tamamura, H, Premanathan, M, Kanbara, K, Ramanan, S, Mochizuki, K, Baba, M, Fujii, N, and Nakashima, H (1999) T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure, J Virol 73: 1719-1723
4. Arthos, J, Deen, KC, Chaikin, MA, Fornwald, JA, Sathe, G, Sattentau, QJ, Clapham, PR, Weiss, RA, McDougal, JS, Pietropaolo, C, et al. (1989) Identification of the residues in human CD4 critical for the binding of HIV, Cell 57: 469-481
5. Ashkenazi, A, Smith, DH, Marsters, SA, Riddle, L, Gregory, TJ, Ho, DD, and Capon, DJ (1991) Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-gp120 binding affinity, Proc Natl Acad Sci USA 88: 7056-7060
6. Baba, M, Nishimura, O, Kanzaki, N, Okamoto, M, Sawada, H, Iizawa, Y, Shiraishi, M, Aramaki, Y, Okonogi, K, Ogawa, Y, et al. (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity, Proc Natl Acad Sci USA 96: 5698-5703
7. Baker, KA, Dutch, RE, Lamb, RA, and Jardetzky, TS (1999) Structural basis for paramyxovirus-mediated membrane fusion, Mol Cell 3: 309-19
8. Baribaud, F, Pohlmann, S, Leslie, G, Mortari, F, and Doms, RW (2002) Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells, J Virol 76: 9135-42
9. Baribaud, F, Pohlmann, S, Sparwasser, T, Kimata, MT, Choi, YK, Haggarty, BS, Ahmad, N, Macfarlan, T, Edwards, TG, Leslie, GJ, et al. (2001) Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN, J Virol 75: 10281-10299
10. Bashirova, AA, Geijtenbeek, TB, van Duijnhoven, GC, van Vliet, SJ, Eilering, JB, Martin, MP, Wu, L, Martin, TD, Viebig, N, Knolle, PA, et al. (2001) A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection, J Exp Med 193: 671-8
11. Basmaciogullari, S, Babcock, GJ, Van Ryk, D, Wojtowicz, W, and Sodroski, J (2002) Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding, J Virol 76: 10791-800
12. Berger, EA, Doms, RW, Fenyo, EM, Korber, BT, Littman, DR, Moore, JP, Sattentau, QJ, Schuitemaker, H, Sodroski, J, and Weiss, RA (1998) A new classification for HIV-1, Nature 391: 240
13. Berger, EA, Murphy, PM, and Farber, JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease, Annu Rev Immunol 17: 657-700
14. Boden, D, Hurley, A, Zhang, L, Cao, Y, Guo, Y, Jones, E, Tsay, J, Ip, J, Farthing, C, Limoli, K, et al. (1999) HIV-1 drug resistance in newly infected individuals, JAMA 282: 1135-41
15. Brenner, BG, Routy, JP, Petrella, M, Moisi, D, Oliveira, M, Detorio, M, Spira, B, Essabag, V, Conway, B, Lalonde, R, et al. (2002) Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection, J Virol 76: 1753-61
16. Bullough, PA, Hughson, FM, Skehel, JJ, and Wiley, DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion, Nature 371: 37-43
17. Carr, A, and Cooper, DA (2000) Adverse effects of antiretroviral therapy, Lancet 356: 1423-30
18. Carr, A, Samaras, K, Thorisdottir, A, Kaufmann, GR, Chisholm, DJ, and Cooper, DA (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study, Lancet 353: 2093-9
19. Chambers, P, Pringle, CR, and Easton, AJ (1990) Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins, J Gen Virol 71: 3075-80
20. Chan, DC, Fass, D, Berger, JM, and Kim, PS (1997) Core structure of gp41 from the HIV envelope glycoprotein, Cell 89: 263-273
21. Choe, H, Farzan, M, Sun, Y, Sullivan, N, Rollins, B, Ponath, PD, Wu, L, Mackay, CR, LaRosa, G, Newman, W, et al. (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates, Cell 85: 1135-1148
22. Clayton, LK, Hussey, RE, Steinbrich, R, Ramachandran, H, Husain, Y, and Reinherz, EL (1988) Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding, Nature 335: 363-6
23. Cocchi, F, DeVico, AL, Garzino-Demo, A, Arya, SK, Gallo, RC, and Lusso, P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells, Science 270: 1811-1815
24. Daar, ES, Li, XL, Moudgil, T, and Ho, DD (1990) High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates, Proc Natl Acad Sci USA 87: 6574-6578
25. Dalgleish, AG, Beverley, PC, Clapham, PR, Crawford, DH, Greaves, MF, and Weiss, RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature 312: 763-767
26. Datema, R, Rabin, L, Hincenbergs, M, Moreno, MB, Warren, S, Linquist, V, Rosenwirth, B, Seifert, J, and McCune, JM (1996) Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry, Antimicrob Agents Chemother 40: 750-4
27. De Clercq, E, Yamamoto, N, Pauwels, R, Balzarini, J, Witvrouw, M, De Vreese, K, Debyser, Z, Rosenwirth, B, Peichl, P, Datema, R, et al. (1994) Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100, Antimicrob Agents Chemother 38: 668-674
28. Deen, KC, McDougal, JS, Inacker, R, Folena-Wasserman, G, Arthos, J, Rosenberg, J, Maddon, PJ, Axel, R, and Sweet, RW (1988) A soluble form of CD4 (T4) protein inhibits AIDS virus infection, Nature 331: 82-84
29. Delwart, EL, Mosialos, G, and Gilmore, T (1990) Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat, AIDS Res Hum Retroviruses 6: 703-6
30. Deng, H, Liu, R, Ellmeier, W, Choe, S, Unutmaz, D, Burkhart, M, Di Marzio, P, Marmon, S, Sutton, RE, Hill, CM, et al. (1996) Identification of a major co-receptor for primary isolates of HIV-1, Nature 381: 661-666
31. Derdeyn, CA, Decker, JM, Sfakianos, JN, Wu, X, O'Brien, WA, Ratner, L, Kappes, JC, Shaw, GM, and Hunter, E (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120, J Virol 74: 8358-67
32. Derdeyn, CA, Decker, JM, Sfakianos, JN, Zhang, Z, O'Brien, WA, Ratner, L, Shaw, GM, and Hunter, E (2001) Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor, J Virol 75: 8605-14
33. Doms, RW (2000) Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection, Virology 276: 229-237
34. Doms, RW, and Peiper, SC (1997) Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry, Virology 235: 179-90
35. Donzella, GA, Schols, D, Lin, SW, Este, JA, Nagashima, KA, Maddon, PJ, Allaway, GP, Sakmar, TP, Henson, G, De Clercq, E, and Moore, JP (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor, Nat Med 4: 72-77
36. Doranz, BJ, Filion, LG, Diaz-Mitoma, F, Sitar, DS, Sahai, J, Baribaud, F, Orsini, MJ, Benovic, JL, Cameron, W, and Doms, RW (2001) Safe use of the CXCR4 inhibitor ALX40-4C in humans, AIDS Res Hum Retroviruses 17: 475-486
37. Doranz, BJ, Grovit-Ferbas, K, Sharron, MP, Mao, SH, Goetz, MB, Daar, ES, Doms, RW, and O'Brien, WA (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor, J Exp Med 186: 1395-1400
38. Doranz, BJ, Rucker, J, Yi, Y, Smyth, RJ, Samson, M, Peiper, SC, Parmentier, M, Collman, RG, and Doms, RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors, Cell 85: 1149-1158
39. Dragic, T, Litwin, V, Allaway, GP, Martin, SR, Huang, Y, Nagashima, KA, Cayanan, C, Maddon, PJ, Koup, RA, Moore, JP, and Paxton, WA (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5, Nature 381: 667-673
40. Dragic, T, Trkola, A, Thompson, DA, Cormier, EG, Kajumo, FA, Maxwell, E, Lin, SW, Ying, W, Smith, SO, Sakmar, TP, and Moore, JP (2000) A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5, Proc Natl Acad Sci U S A 97: 5639-5644
41. Dumonceaux, J, Nisole, S, Chanel, C, Quivet, L, Amara, A, Baleux, F, Briand, P, and Hazan, U (1998) Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype, J Virol 72: 512-519
42. Eckert, DM, Malashkevich, VN, Hong, LH, Carr, PA, and Kim, PS (1999) Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket, Cell 99: 103-15
43. Edinger, AL, Mankowski, JL, Doranz, BJ, Margulies, BJ, Lee, B, Rucker, J, Sharron, M, Hoffman, TL, Berson, JF, Zink, MC, et al. (1997) CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain, Proc Natl Acad Sci USA 94: 14742-14747
44. Edwards, TG, Hoffman, TL, Baribaud, F, Wyss, S, LaBranche, CC, Romano, J, Adkinson, J, Sharron, M, Hoxie, JA, and Doms, RW (2001) Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein, J Virol 75: 5230-5239
45. Endres, MJ, Clapham, PR, Marsh, M, Ahuja, M, Turner, JD, McKnight, A, Thomas, JF, Stoebenau-Haggarty, B, Choe, S, Vance, PJ, et al. (1996) CD4-independent infection by HIV-2 is mediated by fusin/CXCR4, Cell 87: 745-756
46. Este, JA, Cabrera, C, Blanco, J, Gutierrez, A, Bridger, G, Henson, G, Clotet, B, Schols, D, and De Clercq, E (1999) Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4, J Virol 73: 5577-85
47. Fass, D, and Kim, PS (1995) Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin, Curr Biol 5: 1377-83
48. Feinberg, H, Mitchell, DA, Drickamer, K, and Weis, WI (2001) Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR, Science 294: 2163-6
49. Feng, Y, Broder, CC, Kennedy, PE, and Berger, EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science 272: 872-877
50. Fisher, RA, Bertonis, JM, Meier, W, Johnson, VA, Costopoulos, DS, Liu, T, Tizard, R, Walker, BD, Hirsch, MS, Schooley, RT, and Flavell, RA (1988) HIV infection is blocked in vitro by recombinant soluble CD4, Nature 331: 76-78
51. Frank, I, Piatak, M, Jr., Stoessel, H, Romani, N, Bonnyay, D, Lifson, JD, and Pope, M (2002) Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs, J Virol 76: 2936-51
52. Frey, S, Marsh, M, Gunther, S, Pelchen-Matthews, A, Stephens, P, Ortlepp, S, and Stegmann, T (1995) Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type I, J Virol 69: 1462-1472
53. Furuta, RA, Wild, CT, Weng, Y, and Weiss, CD (1998) Capture of an early fusion-active conformation of HIV-1 gp41, Nat Struct Biol 5: 276-9
54. Gallaher, WR, Ball, JM, Garry, RF, Griffin, MC, and Montelaro, RC (1989) A general model for the transmembrane proteins of HIV and other retroviruses, AIDS Res Hum Retroviruses 5: 431-440
55. Gallo, SA, Puri, A, and Blumenthal, R (2001) HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process, Biochemistry (Mosc) 40: 12231-6
56. Gauduin, MC, Allaway, GP, Maddon, PJ, Barbas, CF 3rd, Burton, DR, and Koup, RA (1996) Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules, J Virol 70: 2586-92
57. Gauduin, MC, Allaway, GP, Olson, WC, Weir, R, Maddon, PJ, and Koup, RA (1998) CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates, J Virol 72: 3475-8
58. Geijtenbeek, TB, Kwon, DS, Torensma, R, van Vliet, SJ, van Duijnhoven, GC, Middel, J, Cornelissen, IL, Nottet, HS, KewalRamani, VN, Littman, DR, et al. (2000a) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells, Cell 100: 587-597
59. Geijtenbeek, TB, Torensma, R, van Vliet, SJ, van Duijnhoven, GC, Adema, GJ, van Kooyk, Y, and Figdor, CG (2000b) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses, Cell 100: 575-585
60. Gulick, RM, Mellors, JW, Havlir, D, Eron, JJ, Gonzalez, C, McMahon, D, Richman, DD, Valentine, FT, Jonas, L, Meibohm, A, et al. (1997) Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy, N Engl J Med 337: 734-9
61. Hammer, SM, Squires, KE, Hughes, MD, Grimes, JM, Demeter, LM, Currier, JS, Eron, JJ, Jr., Feinberg, JE, Balfour, HH, Jr., Deyton, LR, et al. (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team, N Engl J Med 337: 725-33
62. Hendrix C., AC, M. Lederman, R. Pollard, S. Brown, M. Glesby, C. Flexner, G. Bridger, K. Badel, R. MacFarland, G. Henson, and G. Calandra, the AMD-3100 HIV Study Group (2002) AMD-3100 CXXCR4 Receptor Blocker Fails to Reduce HIV Viral Load by >1 Log following 10-Day Continuous Infusion. Paper presented at: 9th Conference on Retroviruses and Opportunistic Infections
63. Hladik, F, Lentz, G, Akridge, RE, Peterson, G, Kelley, H, McElroy, A, and McElrath, MJ (1999) Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract, J Virol 73: 5833-42
64. Hoffman, TL, LaBranche, CC, Zhang, W, Canziani, G, Robinson, J, Chaiken, I, Hoxie, JA, and Doms, RW (1999) Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein, Proc Natl Acad Sci USA 96: 6359-6364
65. Hussey, RE, Richardson, NE, Kowalski, M, Brown, NR, Chang, HC, Siliciano, RF, Dorfman, T, Walker, B, Sodroski, J, and Reinherz, EL (1988) A soluble CD4 protein selectively inhibits HIV replication and syncytium formation, Nature 331: 78-81
66. Jacobson, JM, Lowy, I, Fletcher, CV, O'Neill, TJ, Tran, DN, Ketas, TJ, Trkola, A, Klotman, ME, Maddon, PJ, Olson, WC, and Israel, RJ (2000) Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults, J Infect Dis 182: 326-9
67. Kilby, JM, Hopkins, S, Venetta, TM, DiMassimo, B, Cloud, GA, Lee, JY, Alldredge, L, Hunter, E, Lambert, D, Bolognesi, D, et al. (1998) Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry, Nat Med 4: 1302-1307
68. Klatzmann, D, Champagne, E, Chamaret, S, Gruest, J, Guetard, D, Hercend, T, Gluckman, JC, and Montagnier, L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature 312: 767-768
69. Kozak, SL, Heard, JM, and Kabat, D (2002) Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus, J Virol 76: 1802-15
70. Kuhmann, SE, Platt, EJ, Kozak, SL, and Kabat, D (2000) Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1, J Virol 74: 7005-15
71. Kwon, DS, Gregorio, G, Bitton, N, Hendrickson, WA, and Littman, DR (2002) DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection, Immunity 16: 135-44
72. Kwong, PD, Wyatt, R, Robinson, J, Sweet, RW, Sodroski, J, and Hendrickson, WA (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody, Nature 393: 648-659
73. LaBranche, CC, Galasso, G, Moore, JP, Bolognesi, DP, Hirsch, MS, and Hammer, SM (2001) HIV fusion and its inhibition, Antiviral Res 50: 95-115
74. Lambert, DM, Barney, S, Lambert, AL, Guthrie, K, Medinas, R, Davis, DE, Bucy, T, Erickson, J, Merutka, G, and Petteway, SR Jr. (1996) Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion, Proc Natl Acad Sci U S A 93: 2186-91
75. Layne, SP, Merges, MJ, Dembo, M, Spouge, JL, and Nara, PL (1990) HIV requires multiple gp120 molecules for CD4-mediated infection, Nature 346: 277-279
76. Lee, B, Leslie, G, Soilleux, E, O'Doherty, U, Baik, S, Levroney, E, Flummerfelt, K, Swiggard, W, Coleman, N, Malim, M, and Doms, RW (2001) cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor, J Virol 75: 12028-38
77. Lee, B, Sharron, M, Montaner, LJ, Weissman, D, and Doms, RW (1999) Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages, Proc Natl Acad Sci USA 96: 5215-5220
78. Little, SJ, Daar, ES, D'Aquila, RT, Keiser, PH, Connick, E, Whitcomb, JM, Hellmann, NS, Petropoulos, CJ, Sutton, L, Pitt, JA, et al. (1999) Reduced antiretroviral drug susceptibility among patients with primary HIV infection, JAMA 282: 1142-9
79. Liu, R, Paxton, WA, Choe, S, Ceradini, D, Martin, SR, Horuk, R, MacDonald, ME, Stuhlmann, H, Koup, RA, and Landau, NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection, Cell 86: 367-377
80. Lu, M, Blacklow, SC, and Kim, PS (1995) A trimeric structural domain of the HIV-1 transmembrane glycoprotein, Nat Struct Biol 2: 1075-1082
81. Maddon, PJ, Dalgleish, AG, McDougal, JS, Clapham, PR, Weiss, RA, and Axel, R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47: 333-348
82. Maeda, K, Yoshimura, K, Shibayama, S, Habashita, H, Tada, H, Sagawa, K, Miyakawa, T, Aoki, M, Fukushima, D, and Mitsuya, H (2001) Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5, J Biol Chem 276: 35194-200
83. Manes, S, del Real, G, Lacalle, RA, Lucas, P, Gomez-Mouton, C, Sanchez-Palomino, S, Delgado, R, Alcami, J, Mira, E, and Martinez, AC (2000) Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection, EMBO Rep 1: 190-6
84. McDougal, JS, Kennedy, MS, Sligh, JM, Cort, SP, Mawle, A, and Nicholson, JK (1986) Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110 K viral protein and the T4 molecule, Science 231: 382-385
85. Melikyan, GB, Markosyan, RM, Hemmati, H, Delmedico, MK, Lambert, DM, and Cohen, FS (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion, J Cell Biol 151: 413-423
86. Mitchell, DA, Fadden, AJ, and Drickamer, K (2001) A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands, J Biol Chem 276: 28939-45
87. Mizukami, T, Fuerst, TR, Berger, EA, and Moss, B (1988) Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis, Proc Natl Acad Sci U S A 85: 9273-7
88. Mizuochi, T, Matthews, TJ, Kato, M, Hamako, J, Titani, K, Solomon, J, and Feizi, T (1990) Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues, J Biol Chem 265: 8519-24
89. Moore, JP, Burkly, LC, Connor, RI, Cao, Y, Tizard, R, Ho, DD, and Fisher, RA (1993) Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4, AIDS Res Hum Retroviruses 9: 529-539
90. Mosier, DE, Picchio, GR, Gulizia, RJ, Sabbe, R, Poignard, P, Picard, L, Offord, RE, Thompson, DA, and Wilken, J (1999) Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants, J Virol 73: 3544-50
91. Munoz-Barroso, I, Durell, S, Sakaguchi, K, Appella, E, and Blumenthal, R (1998) Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41, J Cell Biol 140: 315-323
92. Murakami, T, Nakajima, T, Koyanagi, Y, Tachibana, K, Fujii, N, Tamamura, H, Yoshida, N, Waki, M, Matsumoto, A, Yoshie, O, et al. (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection, J Exp Med 186: 1389-1393
93. Myszka, DG, Sweet, RW, Hensley, P, Brigham-Burke, M, Kwong, PD, Hendrickson, WA, Wyatt, R, Sodroski, J, and Doyle, ML (2000) Energetics of the HIV gp120-CD4 binding reaction, Proc Natl Acad Sci U S A 97: 9026-31
94. Nagasawa, T, Hirota, S, Tachibana, K, Takakura, N, Nishikawa, S, Kitamura, Y, Yoshida, N, Kikutani, H, and Kishimoto, T (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1, Nature 382: 635-638
95. Nakashima, H, Masuda, M, Murakami, T, Koyanagi, Y, Matsumoto, A, Fujii, N, and Yamamoto, N (1992) Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion, Antimicrob Agents Chemother 36: 1249-55
96. Peterson, A, and Seed, B (1988) Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4, Cell 54: 65-72
97. Platt, EJ, Kuhmann, SE, Rose, PP, and Kabat, D (2001) Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region, J Virol 75: 12266-78
98. Pohlmann, S, Baribaud, F, and Doms, RW (2001a) DC-SIGN and DC-SIGNR: helping hands for HIV, Trends Immunol 22: 643-646
99. Pohlmann, S, Baribaud, F, Lee, B, Leslie, GJ, Sanchez, MD, Hiebenthal-Millow, K, Munch, J, Kirchhoff, F, and Doms, RW (2001b) DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus, J Virol 75: 4664-4672
100. Pohlmann, S, Leslie, GJ, Edwards, TG, Macfarlan, T, Reeves, JD, Hiebenthal-Millow, K, Kirchhoff, F, Baribaud, F, and Doms, RW (2001c) DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions, J Virol 75: 10523-10526
101. Pohlmann, S, Soilleux, EJ, Baribaud, F, Leslie, GJ, Morris, LS, Trowsdale, J, Lee, B, Coleman, N, and Doms, RW (2001d) DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans, Proc Natl Acad Sci U S A 98: 2670-2675
102. Poignard, P, Saphire, EO, Parren, PW, and Burton, DR (2001) gp120: Biologic aspects of structural features, Annu Rev Immunol 19: 253-74
103. Rabin, RL, Park, MK, Liao, F, Swofford, R, Stephany, D, and Farber, JM (1999) Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling, J Immunol 162: 3840-50
104. Reeves, JD, Gallo, SA, Ahmad, N, Miamidian, JL, Harvey, PE, Sharron, M, Pohlmann, S, Sfakianos, JN, Derdeyn, CA, Blumenthal, R, et al. (2002) Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics, Proc Natl Acad Sci U S A 99: 16249-16254
105. Reeves, JD, Hibbitts, S, Simmons, G, McKnight, Azevedo-Pereira, JM, Moniz-Pereira, J, and Clapham, PR (1999) Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo, J Virol 73: 7795-7804
106. Reeves, JD, McKnight, A, Potempa, S, Simmons, G, Gray, PW, Power, CA, Wells, T, Weiss, RA, and Talbot, SJ (1997) CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry, Virology 231: 130-134
107. Reeves, JD, and Schulz, TF (1997) The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion, J Virol 71: 1453-1465
108. Richman, DD (2001) HIV chemotherapy, Nature 410: 995-1001
109. Rimsky, LT, Shugars, DC, and Matthews, TJ (1998) Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides, J Virol 72: 986-993
110. Rizzuto, CD, Wyatt, R, Hernandez-Ramos, N, Sun, Y, Kwong, PD, Hendrickson, WA, and Sodroski, J (1998) A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding, Science 280: 1949-1953
111. Root, MJ, Kay, MS, and Kim, PS (2001) Protein design of an HIV-1 entry inhibitor, Science 291: 884-8
112. Safrin, S, and Grunfeld, C (1999) Fat distribution and metabolic changes in patients with HIV infection, AIDS 13: 2493-505
113. Samson, M, Libert, F, Doranz, BJ, Rucker, J, Liesnard, C, Farber, CM, Saragosti, S, Lapoumeroulie, C, Cognaux, J, Forceille, C, et al. (1996) Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature 382: 722-725
114. Sattentau, QJ, and Moore, JP (1991) Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding, J Exp Med 174: 407-415
115. Sattentau, QJ, and Moore, JP (1995) Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer, J Exp Med 182: 185-196
116. Schols, D, S. Claes, E. De Clercq, C. Hendrix, G. Bridger, G. Calandra, G.W. Henson, S. Fransen, W. Huang, J.M. Whitcomb, C.J. Petropoulos, and AMD-3100 HIV Study Group (2002) AMD-3100, a CXCR4 Antagonist, Reduced HIV VIral Load and X4 Levels in Humans. Paper presented at: 9th Conference on Retroviruses and Opportunistic Infections
117. Schols, D, Struyf, S, Van Damme, J, Este, JA, Henson, G, and De Clercq, E (1997) Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4, J Exp Med 186: 1383-1388
118. Shearer, WT, Israel, RJ, Starr, S, Fletcher, CV, Wara, D, Rathore, M, Church, J, DeVille, J, Fenton, T, Graham, B, et al. (2000) Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team, J Infect Dis 182: 1774-9
119. Smith, DH, Byrn, RA, Marsters, SA, Gregory, T, Groopman, JE, and Capon, DJ (1987) Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen, Science 238: 1704-1707
120. Steinman, RM (2000) DC-SIGN: a guide to some mysteries of dendritic cells, Cell 100: 491-4
121. Strizki, JM, Xu, S, Wagner, NE, Wojcik, L, Liu, J, Hou, Y, Endres, M, Palani, A, Shapiro, S, Clader, JW, et al. (2001) SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo, Proc Natl Acad Sci U S A 98: 12718-23
122. Tachibana, K, Hirota, S, Iizasa, H, Yoshida, H, Kawabata, K, Kataoka, Y, Kitamura, Y, Matsushima, K, Yoshida, N, Nishikawa, S, et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract, Nature 393: 591-594
123. Tamamura, H, Xu, Y, Hattori, T, Zhang, X, Arakaki, R, Kanbara, K, Omagari, A, Otaka, A, Ibuka, T, Yamamoto, N, et al. (1998) A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140, Biochem Biophys Res Commun 253: 877-82
124. Traunecker, A, Luke, W, and Karjalainen, K (1988) Soluble CD4 molecules neutralize human immunodeficiency virus type 1, Nature 331: 84-86
125. Tremblay, MJ, Fortin, JF, and Cantin, R (1998) The acquisition of host-encoded proteins by nascent HIV-1, Immunol Today 19: 346-51
126. Trkola, A, Kuhmann, SE, Strizki, JM, Maxwell, E, Ketas, T, Morgan, T, Pugach, P, Xu, S, Wojcik, L, Tagat, J, et al. (2002) HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use, Proc Natl Acad Sci USA 99: 395-400
127. Trkola, A, Pomales, AB, Yuan, H, Korber, B, Maddon, PJ, Allaway, GP, Katinger, H, Barbas, CF, 3rd, Burton, DR, Ho, DD, et al. (1995) Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG, J Virol 69: 6609-17
128. Turville, SG, Arthos, J, Donald, KM, Lynch, G, Naif, H, Clark, G, Hart, D, and Cunningham, AL (2001) HIV gp120 receptors on human dendritic cells, Blood 98: 2482-8
129. Watanabe, S, Takada, A, Watanabe, T, Ito, H, Kida, H, and Kawaoka, Y (2000) Functional importance of the coiled-coil of the Ebola virus glycoprotein, J Virol 74: 10194-201
130. Weiss, CD, Barnett, SW, Cacalano, N, Killeen, N, Littman, DR, and White, JM (1996) Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay, AIDS 10: 241-6
131. Weissenhorn, W, Calder, LJ, Wharton, SA, Skehel, JJ, and Wiley, DC (1998) The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil, Proc Natl Acad Sci USA 95: 6032-6
132. Weissenhorn, W, Dessen, A, Calder, LJ, Harrison, SC, Skehel, JJ, and Wiley, DC (1999) Structural basis for membrane fusion by enveloped viruses, Mol Membr Biol 16: 3-9
133. Weissenhorn, W, Dessen, A, Harrison, SC, Skehel, JJ, and Wiley, DC (1997) Atomic structure of the ectodomain from HIV-1 gp41, Nature 387: 426-430
134. Wild, C, Greenwell, T, and Matthews, T (1993) A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion, AIDS Res Hum Retroviruses 9: 1051-1053
135. Wild, C, Oas, T, McDanal, C, Bolognesi, D, and Matthews, T (1992) A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition, Proc Natl Acad Sci USA 89: 10537-10541
136. Wu, L, Bashirova, AA, Martin, TD, Villamide, L, Mehlhop, E, Chertov, AO, Unutmaz, D, Pope, M, Carrington, M, and KewalRamani, VN (2002) Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN, Proc Natl Acad Sci USA 99: 1568-73
137. Yerly, S, Kaiser, L, Race, E, Bru, JP, Clavel, F, and Perrin, L (1999) Transmission of antiretroviral-drug-resistant HIV-1 variants, Lancet 354: 729-33
138. Zhang, Y, Lou, B, Lal, RB, Gettie, A, Marx, PA, and Moore, JP (2000) Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells, J Virol 74: 6893-6910
139. Zhu, P, Olson, WC, and Roux, KH (2001) Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes, J Virol 75: 6682-6
140. Zou, YR, Kottmann, AH, Kuroda, M, Taniuchi, I, and Littman, DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development, Nature 393: 595-599